Vanguard Global Advisers’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$642K Buy
8,874
+457
+5% +$35.4K ﹤0.01% 1982
2026
Q2
$578K Sell
8,417
-2,558
-23% -$145K ﹤0.01% 2035
2026
Q1
$705K Buy
+10,975
New +$1M ﹤0.01% 1853

Other funds holding WGS

Vanguard Global Advisers's WGS Position: Q3 2026 in Review

Vanguard Global Advisers increased its GeneDx Holdings (WGS) stake by 5.4% in Q3 2026, buying an estimated $35.4K and bringing the position to 8,874 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Vanguard Global Advisers first reported a position in WGS in Q1 2026 and has held it in 3 quarters since. The position peaked at $705K in Q1 2026. 219 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Vanguard Global Advisers held 8,874 shares of GeneDx Holdings worth $642K as of Q3 2026.
  • Vanguard Global Advisers bought 457 GeneDx Holdings shares in Q3 2026, an estimated $35.4K.
  • GeneDx Holdings made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1982 holding.
  • Vanguard Global Advisers first reported a position in GeneDx Holdings in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's GeneDx Holdings position peaked at $705K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.